381 related articles for article (PubMed ID: 19703934)
21. Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells.
Mehta A; Chung YY; Ng A; Iskandar F; Atan S; Wei H; Dusting G; Sun W; Wong P; Shim W
Cardiovasc Res; 2011 Sep; 91(4):577-86. PubMed ID: 21565833
[TBL] [Abstract][Full Text] [Related]
22. Cardiomyocyte differentiation of human induced pluripotent stem cells.
Zwi L; Caspi O; Arbel G; Huber I; Gepstein A; Park IH; Gepstein L
Circulation; 2009 Oct; 120(15):1513-23. PubMed ID: 19786631
[TBL] [Abstract][Full Text] [Related]
23. Calcium handling in embryonic stem cell-derived cardiac myocytes: of mice and men.
Itzhaki I; Schiller J; Beyar R; Satin J; Gepstein L
Ann N Y Acad Sci; 2006 Oct; 1080():207-15. PubMed ID: 17132785
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation.
Brodarac A; Šarić T; Oberwallner B; Mahmoodzadeh S; Neef K; Albrecht J; Burkert K; Oliverio M; Nguemo F; Choi YH; Neiss WF; Morano I; Hescheler J; Stamm C
Stem Cell Res Ther; 2015 Apr; 6(1):83. PubMed ID: 25900017
[TBL] [Abstract][Full Text] [Related]
25. Functional sarcoplasmic reticulum for calcium handling of human embryonic stem cell-derived cardiomyocytes: insights for driven maturation.
Liu J; Fu JD; Siu CW; Li RA
Stem Cells; 2007 Dec; 25(12):3038-44. PubMed ID: 17872499
[TBL] [Abstract][Full Text] [Related]
26. Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype.
Pekkanen-Mattila M; Chapman H; Kerkelä E; Suuronen R; Skottman H; Koivisto AP; Aalto-Setälä K
Exp Biol Med (Maywood); 2010 Apr; 235(4):522-30. PubMed ID: 20407085
[TBL] [Abstract][Full Text] [Related]
27. Ontogenic development of cardiomyocytes derived from transgene-free human induced pluripotent stem cells and its homology with human heart.
Sequiera GL; Mehta A; Ooi TH; Shim W
Life Sci; 2013 Jan; 92(1):63-71. PubMed ID: 23142239
[TBL] [Abstract][Full Text] [Related]
28. Recent advances in cardiovascular regenerative medicine: the induced pluripotent stem cell era.
Yuasa S; Fukuda K
Expert Rev Cardiovasc Ther; 2008 Jul; 6(6):803-10. PubMed ID: 18570618
[TBL] [Abstract][Full Text] [Related]
29. Sox2 transduction enhances cardiovascular repair capacity of blood-derived mesoangioblasts.
Koyanagi M; Iwasaki M; Rupp S; Tedesco FS; Yoon CH; Boeckel JN; Trauth J; Schütz C; Ohtani K; Goetz R; Iekushi K; Bushoven P; Momma S; Mummery C; Passier R; Henschler R; Akintuerk H; Schranz D; Urbich C; Galvez BG; Cossu G; Zeiher AM; Dimmeler S
Circ Res; 2010 Apr; 106(7):1290-302. PubMed ID: 20185800
[TBL] [Abstract][Full Text] [Related]
30. Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro.
Malan D; Friedrichs S; Fleischmann BK; Sasse P
Circ Res; 2011 Sep; 109(8):841-7. PubMed ID: 21799153
[TBL] [Abstract][Full Text] [Related]
31. Oct4-induced pluripotency in adult neural stem cells.
Kim JB; Sebastiano V; Wu G; Araúzo-Bravo MJ; Sasse P; Gentile L; Ko K; Ruau D; Ehrich M; van den Boom D; Meyer J; Hübner K; Bernemann C; Ortmeier C; Zenke M; Fleischmann BK; Zaehres H; Schöler HR
Cell; 2009 Feb; 136(3):411-9. PubMed ID: 19203577
[TBL] [Abstract][Full Text] [Related]
32. Strategies toward CNS-regeneration using induced pluripotent stem cells.
Okano H
Genome Inform; 2009 Oct; 23(1):217-20. PubMed ID: 20180278
[TBL] [Abstract][Full Text] [Related]
33. Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts.
Gai H; Leung EL; Costantino PD; Aguila JR; Nguyen DM; Fink LM; Ward DC; Ma Y
Cell Biol Int; 2009 Nov; 33(11):1184-93. PubMed ID: 19729070
[TBL] [Abstract][Full Text] [Related]
34. [Induced pluripotent stem cells].
Shevchenko AI; Medvedev SP; Mazurok NA; Zakiian SM
Genetika; 2009 Feb; 45(2):160-8. PubMed ID: 19334609
[TBL] [Abstract][Full Text] [Related]
35. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage.
Li F; Bronson S; Niyibizi C
J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314
[TBL] [Abstract][Full Text] [Related]
36. Genomic analysis of induced pluripotent stem (iPS) cells: routes to reprogramming.
Kanawaty A; Henderson J
Bioessays; 2009 Feb; 31(2):134-8. PubMed ID: 19204985
[TBL] [Abstract][Full Text] [Related]
37. Oct4 and klf4 reprogram dermal papilla cells into induced pluripotent stem cells.
Tsai SY; Clavel C; Kim S; Ang YS; Grisanti L; Lee DF; Kelley K; Rendl M
Stem Cells; 2010 Feb; 28(2):221-8. PubMed ID: 20014278
[TBL] [Abstract][Full Text] [Related]
38. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells.
Tat PA; Sumer H; Jones KL; Upton K; Verma PJ
Cell Transplant; 2010; 19(5):525-36. PubMed ID: 20144262
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling of functional murine embryonic stem cell-derived cardiomyocytes and comparison with adult heart: profiling of murine ESC-derived cardiomyocytes.
Shinozawa T; Tsuji A; Imahashi K; Nakashima K; Sawada H; Toyoshiba H; Yamamoto S; Takami K; Imai R
J Biomol Screen; 2009 Mar; 14(3):239-45. PubMed ID: 19211779
[TBL] [Abstract][Full Text] [Related]
40. Induction of pluripotency in human cord blood unrestricted somatic stem cells.
Zaehres H; Kögler G; Arauzo-Bravo MJ; Bleidissel M; Santourlidis S; Weinhold S; Greber B; Kim JB; Buchheiser A; Liedtke S; Eilken HM; Graffmann N; Zhao X; Meyer J; Reinhardt P; Burr B; Waclawczyk S; Ortmeier C; Uhrberg M; Schöler HR; Cantz T; Wernet P
Exp Hematol; 2010 Sep; 38(9):809-18, 818.e1-2. PubMed ID: 20541586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
